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ABSTRACT
Normal and pathological forms of aging, such as Alzheimer’s Disease, are 
characterized by declines in attention and neuroplasticity. However, the 
underlying neurobiological changes associated with cognitive deterioration 
have not been fully characterized. This paper describes two experiments that 
strive to further the understanding of these two age-related cognitive declines. 
Experiment 1 investigated the interaction between GABAergic basal forebrain 
neurons and the cholinergic system and how these systems separately and in 
combination with one another affect performance on the two-choice sustained 
attention task for rats. The results from experiment 1 found that immunotoxic 
GABAergic basal forebrain neurons lesions left animals more susceptible to the 
attentional deficits due to the blocking of muscarinic receptors with 
scopolamine. Experiment 2 tested the effects of the addition of a flashing 
houselight distracter on neuroplasticity in aged rats. This was conducted 
through comparing performance in animals that had the addition of a flashing 
houselight distracter and those that performed with a stable houselight on a 
learned two-choice sustained attention task and a newly introduced light- 
location discrimination task. The results from experiment 2 indicated that once 
the rats were able to overcome the initial increase in attentional demand due 
the flashing houselight, the distracter-exposed animals showed an increase in 
attentional performance during the 25 ms signal duration trials during the 
sustained attention task beyond the non-distracter-exposed animals while 
maintaining performance on the other attention trial types. However, 
cholinergic manipulations due to injections of scopolamine and nicotine did not 
differentially alter performance for the distracter-exposed versus the non- 
distracter-exposed rats. These results indicate that the ability to overcome high 
attentional demands may increase neuroplasticity in aged rats.
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Age-related cognitive decline can range from mild confusion and memory loss 
to severe dementia and Alzheimer’s Disease (AD). Declines in aged individuals’ 
cognitive function can include changes in attention, memory, learning, executive 
function, and language capabilities that can negatively affect quality of life, personal 
relationships, and the capacity for making informed decisions about health care and 
other matters (Wagster, King, Resnick, & Rapp, 2012). As of 2013, an estimated 16 
million people are living with cognitive impairment due to aging. Another 5 million 
Americans 65 and older are thought to have AD (Hebert, Weuve, Scherr, & Evans, 
2013).
Moreover, treating cognitive decline is extremely costly. Patients with cognitive 
impairment report more than three times as many hospital stays beyond those who are 
hospitalized for other conditions (Bynum, 2009). For people with conditions related to 
cognitive decline, aggregate payments for health care, long-term care, and hospice are 
projected to increase from $203 billion in 2013 to $1.2 trillion per year in 2050 
(Alzheimer's Association, 2013). According the Centers for Disease Control, this not 
only makes cognitive decline and AD mental health problems that affect the elderly but 
also a public health issue (“Cognitive Impairment: A Call for Action, Now!”, 2011).
Researching the neural circuitry that underlies the difficulties related to 
cognitive decline may lead to the development of more targeted pharmacological 
treatments and a better understanding about the effects that pharmacological treatments 
have within the brain. The experiments that are the focus of this paper were designed to 
examine two of the most common issues associated with age-related cognitive decline:
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decreased attention and plasticity. The experiments will further investigate how 
changes in neurotransmitter systems may contribute to these two effects of aging.
Basal Forebrain and Attention
Cholinergic Neurons. The basal forebrain (BF) is comprised of a collection of 
subcortical structures located ventral and rostral to the striatum that include the medial 
septum, ventral pallidum, diagonal band nuclei, substantia innominata/extended 
amygdala, and peripallidal regions (Mesulam, Mufson, Wainer, & Levey, 1983). 
Neurons located within the BF essentially project to all cortical areas and layers 
(Similey, Subramanian, & Mesulam, 1999). Furthermore, cortically projecting 
acetylcholine (ACh)-releasing neurons, or cholinergic neurons, from the BF have been 
shown to impact a number of cognitive functions and behaviors such as attention, 
impulsivity, wakefulness, drug abuse, cognitive decline due to aging and a number of 
psychiatric disorders (Zaborszky, van den Pol, & Gyengesi, 2012).
A two-choice sustained attention task has been widely used in animal models to 
investigate the neural underpinnings, including the BF ACh projections, that contribute 
to attentional processing. This task requires the animal to respond to two different trial 
types. On signal trials, the light is illuminated for variable short durations and on non­
signal trials the light is not illuminated. The subjects are trained to press one of two 
levers to receive a reward of water for signal trials and the other lever to receive a 
reward on the non-signal trials. Many studies have used this task to highlight the 
importance of the BF cholinergic system on performance in this task (i.e. McGaughy & 
Sarter, 1999; McGaughy & Sarter, 1995).
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Previous studies provide evidence of the importance of BF ACh projections 
using a variety of methods to manipulate or measure the activity of this system during 
performance in this two-choice sustained attention task. For example, a number of 
experiments have used the immunotoxin 192 IgG-saporin to pharmacologically lesion 
ACh neurons within the BF through targeting and eliminating p75NTRpositive neurons 
and assess subsequent task performance. The 192 IgG-saproin complex is an antibody 
that binds with high specificity to the p75 nerve growth factor receptor and is then 
endocytosed which allows the saporin to inactivate the ribosomes within the cell 
leading to cell death. P75NTR is only expressed in cholinergic neurons and not in 
neighboring non-cholinergic neurons within the area (Wrenn & Wiley, 1998; 
http://www.atsbio.com/catalog/toxins/it01.php). Therefore, the use of this 
immunotoxin leads to cholinergic cell death but the preservation of other non- 
cholinergic neurons. These studies then tested the effects of the cholinergic lesion 
using different attention tasks (i.e. Gibbs & Johnson, 2007; McGaughy, Kaiser, & 
Sarter, 1996). The results from both of these previous studies indicate that lesioning the 
cholinergic system within the BF leads to poorer attention performance especially 
when examining the trials when a visual signal needs to be detected.
Measurement of ACh release in rats using in vivo microdialysis during a visual
sustained attention task found higher ACh levels within medial preffontal cortex during
this task compared with ACh release during performance of a task that controlled for
lever pressing and reward access, but did not require explicit attention to visual cues
(Arnold, Burk, Hodgson, Sarter, & Bruno, 2002). An additional study examined
extracellular recordings of posterior parietal cortex (PPC) neurons after selectively
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removing ACh projections from the BF to the recording site. After the removal of ACh 
projections, fewer neurons within the PPC fired when a cue directed stimulus was 
presented but more PPC neurons fired when distracter stimuli were presented. These 
results imply an association between cholinergic activation and PPC neural response to 
stimuli that increase demands on attentional processing (Broussard, Karelina, Sarter, & 
Givens, 2009). All of these studies contribute evidence supporting the conclusion that 
ACh cortical projections from the BF are a critical aspect of the neural circuitry 
underlying attentional ability.
Several theories regarding the cholinergic modulation of attention have been
suggested. One prominent theoiy proposes that activation of the cholinergic system
optimizes cognitive and sensory components of attentional performance through
contributing to both top-down and bottom-up processing (Sarter, Bruno, & Givens,
2003). As defined in Sarter, Givens, & Bruno (2001), top-down regulation indicates an
internally motivated, knowledge driven guidance of attention whereas bottom-up
regulation of attention indicates a sensory or environmental influence on attention.
Top-down processing within the two-choice sustained attention task would indicate the
subject’s knowledge as to where to look for a signal, capacity to discern between a
signal and a distracter, awareness of the general probability of a signal and ability to
apply the rules of the task to properly respond to that signal. Evidence has also shown
that the BF corticopetal cholinergic system is key in an organism’s top-down control
and ability to switch between rules for signal and non-signal trials (Howe et al., 2013).
Bottom-up processing m the two-choice sustained attention task 'would be the animal s
ability to distinguish sensory information. Theoretical models have proposed that the
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cholinergic system may be important for the integration of bottom-up and top-down 
aspects of attention (Yu & Dayan, 2002). This theory suggests that perception and 
attention involves inferring the most appropriate representation for sensory inputs. This 
inference is influenced by both top-down inputs, providing contextual and probability 
information, and bottom-up inputs from sensory processing. The authors propose that 
ACh reports on the uncertainty associated with top-down information, and has the 
effect of modulating the relative strengths of input sources associated with bottom-up 
information. In combination, the evidence to date suggests that ACh optimizes multiple 
components of attentional processing.
Non-Cholinergic Neurons. Although the cholinergic system within the BF has
been the focus of much of the previous research on the area and attention, there are
other populations of neurons within the BF, namely gamma-aminobutyric acid
(GABA) transmission. In fact, GABAergic neurons outnumber ACh neurons within the
globus pallidus/substantia innominata region of the BF (9,600 vs. 5,100 cells/
hemisphere; Gritti, Mainville, & Jones, 1993). Given the relatively large number of
non-cholinergic neurons intermingled with cholinergic neurons within the BF, any
satisfactory theory of the role of the BF in attention needs to include an understanding
of the contributions of non-cholinergic neurons along with their interactions with the
cholinergic neurons (Sarter, Lustig, Howe, Gritton, & Berry, 2014; Baxter & Bucci,
2013). In order to investigate this relationship, Burk and Sarter (2001) administered
either 192 IgG-saporin (which damages only cholinergic neurons) or ibotenic acid
(which preferentially, but not selectively, damages non-cholinergic neurons) to tne jor
of rats. The animals were then tested on a two-choice sustained attention task
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previously described by McGaughy & Sarter (1995). The results from this experiment 
showed that attentional performance in the ibotenic acid-induced lesioned animals had 
a different pattern of deficits when compared to the 192 IgG-saporin lesioned animals. 
Ibotenic acid-induced lesions increased false alarms (incorrect responses on trials when 
no visual signal was provided). This result contrasts with the typical effect of BF 
cholinergic lesions, a decrease in the hit rate (more errors on trials when a visual signal 
is presented). This indicates that there is a key difference in the attentional effects of 
selective cholinergic lesions as compared with lesions that preferentially, but not 
selectively, destroy non-cholinergic neurons in the BF.
Recent studies have built upon these findings to provide further evidence of the 
role of non-cholinergic neurons in attention. For example, Lin and Nicolelis (2008) 
used a Go/NoGo task that linked auditory and visual cues to reward and aversive 
stimuli to provide neurophysiological evidence of the role of non-cholinergic BF 
neurons on attention in rats. The results showed phasic bursting of non-cholinergic BF 
neurons during the encoding of both reward and adverse cues implicating these 
neurons in the encoding attention to cues along with subsequent action toward 
motivationally salient stimuli. These results implicate non-cholinergic BF neurons in 
the attentional encoding of both positive and negative motivational stimuli.
Furthermore, Yi and colleagues (2014) demonstrated the interaction between 
cholinergic muscarinic-1 (Mi) receptors and GAB A transmission. This study, using a 
mouse model, provided evidence that excitation of Mi cholinergic receptors on
n o tn  rn l 1m irv\ i «  rv n  ai l f A t i  n ( t-%i i f n f n  m O  A 13 A -r> a i i t ir» n ra n  OA/1 a  A 13 A A fA l A
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activity within hippocampal cells. However, because of a lack of available agents to
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selectively lesion non-cholinergic neurons, previous research has mostly ignored the 
function of non-cholinergic neurons within the BF (Baxter & Bucci, 2013).
Aging and Attention: Underlying Neural Circuitry
Cholinergic Neurons. The cholinergic hypothesis of age related cognitive 
decline indicates that the cognitive impairment seen in AD patients and potentially 
normally aging elderly people is due primarily to loss of ACh neurons (Bartus, Dean, 
Beer, & Lippa, 1982). Since its original proposal in 1982, research on both normal and 
AD populations has supported and elaborated upon this theory.
Research with animal models has confirmed that BF lesions to cholinergic 
neurons render animals more vulnerable to attentional decline due to aging (Burk, 
Herzog, Porter, & Sarter, 2002). This longitudinal study found that partial 192 IgG- 
saporin-induced lesions of BF ACh neurons early in life decrease sustained attention 
performance later in life (31 months) when compared to animals who received sham 
lesions. Additional studies have found BF cholinergic lesions produced by 192 IgG- 
saporin dampened the cognition-enhancing effects of a complex environmental 
stimulus in combination with the administration of a benzodiazepine receptor weak 
inverse agonist (Fadel, Sarter, & Bruno, 1999). This study also showed that aged 
lesioned rats had significantly lower cortical ACh efflux in this complex environment 
when compared to sham and lesion young rats and sham aged rats. Moreover, human 
volumetric studies of BF neurons show an increase in atrophy of the cholinergic system 
that is associated with normal aging (Grothe, Heinsen, & Teipel, 2012; 2013). All of 
these findings point to the importance of the cholinergic system in the maintenance of 
attention abilities into aging.
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Previous research has indicated that AD patients have significantly fewer BF 
ACh-releasing neurons when compared to age-matched controls (Nagai, McGeer,
Peng, McGeer, & Dolman, 1983). One study found that fewer choline 
acetyltransferase-positive neurons in the BF may be one of the main underlying 
mechanisms that causes cognitive decline in AD patients (Coyle, Price, & DeLong, 
1983). In combination, this research highlights the importance of BF ACh connections 
for cognitive aging and signifies that the cholinergic system is key in the maintenance 
of cognitive and attentional abilities in both normal and pathological aging.
Non-Cholinergic Neurons (Glutamate/GABA). Research has highlighted that
the number of GABAergic neurons changes in both normally aged and AD patients
compared with earlier in life. The quantity of GABAergic neurons throughout the brain
increases with age with an even larger increase in AD patients (Banuelos et al., 2013;
Marczynshi, 1998). This increase in GAB A neurons is due to an increase in activity of
glutamic acid decarboxylase (GAD). GAD is the enzyme which converts glutamate
into GABA. There are two forms of GAD within the brain, active and inactive. GAD
needs a cofactor to be in its active form. Mitochondrial adenosine triphosphate
production (ATP) and amino acids (ATP is probably the most critical with regard to
aging) promote the inactive form of GAD (Martin & Rimvall, 1993). However, in
aging, disruption of ATP activity leads to the disinhibition of active GAD activity
meaning that GAD is more often in its active form (Beal, Hyman, & Koroshetz, 1993).
This increase in active GAD activity decreases the number of glutamate releasing
neurons while increasing the number of GABA releasing neurons (Martin, 1987).
Glutamate and GABA have inverse functions throughout the brain. While glutamate is
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typically considered a major excitatory neurotransmitter, GABA is considered the 
major inhibitory neurotransmitter, although the specific actions depend on the 
receptors. Additionally, glutamate is a precursor to GABA and once GAD transforms a 
glutamate-releasing neuron into a GABA-releasing neuron it produces a combination 
of decreased excitatory and increased inhibitory neuron firing throughout the brain. It 
has also been shown that the down regulation of post-synaptic glutamate receptor 
activity plays a role in cognitive impairments associated with age (Burke & Barnes, 
2010; Menard, 2015) This change in ratio of neurons within the brain has been 
theorized to be one neurological cause of the cognitive decline found throughout 
normal aging (Mora, Segovia, & del Arco, 2007).
Collectively, there is a shift in increased GABA neurons and decreased 
cholinergic activity that happens with age which has been theorized to lead to cognitive 
decline. This gives rise to the importance of investigating the interaction between the 
GABAergic and cholinergic systems and how they may affect executive functions such 
as attention.
Aging and Plasticity
Plasticity is broadly defined as an organism’s ability to adapt and change in
accordance to changes in the demands placed on the organism such as an increase in
irrelevant sensory information during target detection. Presumably, the flexibility that
allows an organism to learn and adapt to these changes is due to modifications in brain
connectivity including increases in brain size, cortical thickness, neuron size, dendritic
branching, spine density, synapses per neuron and glial numbers (Kolb & Whishaw,
1998) otherwise referred to neuroplasticity. Kolb & Wishaw (1998) maintain that
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neuroplasticity tends to be more limited with increased age. Increasing learning and 
neuroplasticity may potentially rescue some aspects of age related cognitive decline 
(i.e. Jones et at., 2006; Kramer & Willis, 2003; Nyberg et al., 2003).
Bherer and colleagues (2005, 2006) tested the flexibility of attentional control 
in older adults using a dual attention task. For this study, participants completed two 
attention tasks. In one task, participants were asked to indicate on a key board whether 
a B or a C was presented on the screen in front of them. In the second task, participants 
indicated whether a low or high pitch tone was played by pressing one of two other 
keys on a key board. In each session, there were blocks of solely visual or auditory 
trials and blocks where both were presented at once. Participants were first brought 
into the lab and completed a session, and then they were brought back into the lab for 
five training sessions where they were given continuous, adaptive feedback after each 
trial as to whether their performance was adequate or too slow. Feedback was only 
given for the five training sessions and not for the initial or final testing session. The 
results from this study indicated that although younger adults had overall faster 
reaction times and higher accuracy, improvement in performance was equivalent for 
both age groups by the final session. Furthermore, research conducted using the field of 
view task (defined as the visual area in which information can be acquired within one 
eye fixation) revealed that both older and younger adults successfully increase 
performance with training (Ball, Beard, Roenker, Miller, & Griggs, 1988). These 
findings support the theory that flexibility of attentional control is possible in older 
adults, as evidenced by task improvement with practice and points to potential 
neuroplasticity.
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Previous studies have added a flashing houselight during the two-choice 
sustained attention task to examine the rat’s ability to adapt and continue to perform 
with an increased cognitive load (McGaughy & Sarter, 1995). Demeter, Sarter, and 
Lustig (2008) investigated the translatability of manipulations to two-choice sustained 
attention task, typically used with rats, to human attention. For this study, the 
researchers, in separate experiments, trained rats on the two-choice sustained attention 
task and brought humans into a laboratory setting to complete a similar task on a 
computer. A distracter was introduced to the rats and humans by flashing a houselight 
and having the background flash on the computer screen, respectively. The data 
showed that although humans had overall higher performance on the task, both rats and 
humans showed a similar pattern of better performance at the longer signal durations 
without the addition of the distracter and decreased performance at the shortest signal 
duration after the addition of the flashing distracter. These results support the 
translatability of the sustained attention task features from rats to humans.
The addition of a flashing houselight during the task has also been shown to
increase cognitive flexibility and ability to learn a new task (Hirsh & Burk, 2013). For
this study, rats trained on the two-choice sustained attention task described by
McGaughy and Sarter (1995) until they reached criterion performance. The rats were
then randomly assigned to one of two conditions. One group continued on sessions
with a consistently illuminated houselight and the other group had the addition of a
flashing houselight as a distracter. After the initial distracter exposure of 12 sessions,
blocks of a new light-location task were intermixed within the sustained attention task
for both groups. For this new task, animals were required, after illumination of a right
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or left signal light, to press the lever under the light to receive water reward access. 
Results from this study showed that the initial introduction of the distracter decreased 
performance, however, with additional training both the distracter- and non-distracter- 
exposed animals had similar performance in the sustained attention task. The addition 
of 10% of new light-location task trials showed no difference in performance between 
groups for either task. However, at 40% of the new light-location task blocks, the rats 
in the distracter condition had increased performance in the light-location task beyond 
that of the non-distracter animals while maintaining similar performance in the 
sustained attention task. These results indicate that the ability to overcome increases 
the attentional demand (the flashing houselight) and regain good attentional 
performance therefore further increases the neuroplasticity and thus ability to adapt to 
and perform in the new light-location task without sacrificing performance in the two- 
choice sustained attention task.
Cholinergic System and Plasticity. A number of studies have investigated
how the addition of a distracter in the form of the flashing houselight during the
sustained attention task is associated with increased cortical ACh release (Gill, Sarter,
& Givens, 2000; Newman & McGaughy, 2008). These studies indicate that the
increased attentional demands due to the distracter stimulate cortical ACh release.
Furthermore, neural changes within the cholinergic system may contribute to the
animal’s ability to overcome the additional load associated with the flashing houselight
distracter and maintain attentional performance (Himmelheber, Sarter, & Bruno, 2000).
This relationship was elucidated by the in vivo microdialysis measurements of ACh
efflux within the frontoparietal cortex while the rats performed the sustained attention
12
task. The results from this experiment showed a complex relationship between ACh 
release and performance on the task. As aligned with previous studies, the initial 
distracter exposure decreased attentional performance. However, the recovery in 
performance was accompanied by an increase in ACh release. These findings suggest 
that the augmentation of attentional demand produced by the distracter and the 
compensation of the animal for that distracter to recover performance elicits further 
increases in ACh release.
The mechanisms through which ACh may influence neuroplasticity are 
beginning to be elucidated. A review by McKay, Placzek, and Dani (2007) cites 
multiple mechanisms through which the cholinergic system may affect neural 
plasticity. ACh can facilitate depolarization of postsynaptic neurons by blocking K+ 
channels, thereby promoting NMDA-mediated glutamate release. Additionally, ACh 
may independently initiate plasticity through production of protein kinase II or other 
intracellular mechanisms. These modes through which ACh acts to alter 
neurotransmitter transmission indicates that the cholinergic system may key in the 
development of neuroplasticity.
Furthermore, there are now data documenting the effects of ACh on
neuroplasticity with changes in behavior. Research has associated alterations to the
cholinergic system to both neuroplasticity and behavioral flexibility (Conner,
Culberson, Packowski, Chiba, & Tuszynski, 2003). The researchers found that BF
cholinergic lesions are associated with decreased cortical plasticity as measured by
electrophysiological stimulation to the sensory motor cortex and behavioral flexibility
in a skilled motor task that required the rats to reach for food pellets. These lesions also
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impaired learning in the skilled motor task. The lesions removed any prior increases in 
performance due to the learning of the task. Linking ACh neuroplasticity and 
behavioral flexibility further supports the theory of codependence between 
neurological and behavioral changes.
Current Studies and Hypotheses
Experiment 1. The goal of the first experiment is to build upon previous 
findings by testing whether there are interactions between cholinergic muscarinic 
receptors and GABAergic neurons in the BF that affect attentional processing in order 
to better understand one of the main symptoms of cognitive decline associated with 
aging. To produce surgical lesions, the animals received the selective GABAergic 
immunotoxin, GATl-saporin. This is an immunotoxin that selectively binds to and 
destroys GABAergic neurons while preserving cholinergic neurons by only attaching 
to and deactivating the neurotransmitter transporter that is responsible for the 
movement of GABA across cell membranes 
(http ://www. atsbio .com/ catalog/toxins/it3 2 .php).
The animals then received injections of the muscarinic receptor antagonist, 
scopolamine, prior to testing. By examining the effects of lesions of BF GABA 
neurons and the acute blocking of cholinergic muscarinic receptors, the results of this 
experiment will lead to a better understanding of how these two systems may interact 
to affect attentional performance. Based on the results from previous studies testing the 
effect of cholinergic and non-cholinergic BF neurons (Yi et al., 2014; Burk & Sarter, 
2001; Lau & Salzman, 2008) it is predicted that there will be an interaction between
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the GABAergic BF neurons and cholinergic system that will decrease attentional 
performance.
Experiment 2. Previous research in our lab has revealed that, in young adult 
rats, the addition of a flashing houselight during a learned two-choice sustained 
attention task enhances rats’ ability to learn a new light-location task (Hirsh & Burk, 
2013). The authors concluded that the initial introduction of the distracter decreased 
performance, however, learning to overcome the distracter and maintain performance 
increased cognitive flexibility leading to faster acquisition of a light-location task. The 
present experiment was designed to test whether this form of plasticity extends to aged 
rats and if manipulations to the cholinergic system further alter that plasticity.
Rats were trained on a two-choice sustained attention task from ages 3 months 
until age 20 months (approximately equivalent to 50 human years; Sengupta, 2013). At 
20 months half of the rats continued on the same task with no manipulations and half 
continued on the task with the addition of a flashing house light. After 20 sessions of 
this manipulation, blocks of a novel light-location discrimination task were added. 
Finally, to measure the effect of alterations to the cholinergic system, all animals then 
received injections of scopolamine (muscarinic receptor antagonist) and nicotine 
(nicotinic receptor agonist) prior to testing.
Sustained attention and the light-location discrimination performance were
evaluated after each task manipulation. Based on the results from Hirsh & Burk (2013),
it is predicted that those animals in the distracter group will initially show poorer
attentional performance. However, they will be able to eventually compensate for the
distraction and showing improved performance in the sustained attention and the light-
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location discrimination tasks. Because these are aged animals, these effects may not be 
as strong as those seen in the previous experiment. Furthermore, it is predicted there 
will be accelerated learning for the distracter- exposed animals over the non-distracter- 
exposed animals for the light-location trials while maintaining performance in the 
sustained attention at the 40% and 70% light-location discrimination sessions. 
Regarding drug administration, because decreased muscarinic receptor stimulation has 
been shown to decrease attention and stimulating nicotinic receptors can improve
attention (i.e. Rezvani & Levin, 2001), it is predicted that injections of scopolamine
*
will decrease performance and, inversely, injections of nicotine will increase 
performance.
Method 
Experiment 1
Subjects. Male FBNF1 hybrid rats (N  = 16; National Institute of Aging 
Colony), aged 2 months at the beginning of the training, were used for this experiment. 
Rats were trained in the task daily beginning between the hours of 9:00 AM and 12:00 
PM. When the animals were not being tested they were housed in plastic flat-bottom 
tubs in a temperature and humidity controlled room on a 14/10 hour light/dark cycle 
and were given food ad libitum. After completion of a training session rats were 
returned to their home cases and water access was given freely to the rats for 30 
minutes. On days when the animals were not trained, water was given for one hour. All 
housing and testing methods were approved by the College of William and Mary 
Institutional Animal Care and Use Committee (IACUC).
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Apparatus. Animals were trained in individual chambers, located within sound 
attenuating boxes with fans providing ventilation and background noise during testing. 
The testing chamber within each box contained one house light at the back which was 
consistently illuminated during the final stage of testing. Additionally, the chamber 
contained three panel lights at the opposite side of the box. Below the left and right 
panel lights there were two retractable levers and between the levers, a water dipper 
was used to provide access to 0.01 ml of tap water to the animal. All trials were 
controlled by MED-PC IV software.
Pre-surgical Training: Two Choice Sustained Attention Task. The rats were 
first shaped by receiving water access (dipper raised for 3 s) following every lever 
press, with the rule that, if the rat pressed the same lever five times, it had to press the 
other lever to receive reward. This rule was intended to minimize the development of a 
lever bias. After reaching a criterion of receiving 100 rewards for at least three testing 
session, rats were moved to the next training stage. The next training stage consisted of 
two types of trials, signal and non-signal. On the signal trials the central panel light 
would illuminate for 1 s and the response levers would then extend into the chamber. 
The animals were required to press one of the two levers in order to register a response. 
The correct response lever was counterbalanced between rats. For half of the animals, a 
right lever press on signal trials was considered correct and for the other half of the 
animals the left lever press was considered correct on signal trials. For non-signal 
trials, the panel light did not illuminate and the levers were extended into the chamber. 
For a correct response on these non-signal trials, rats were trained to press the opposite
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lever than what was correct for the signal trials. After a correct response on a signal or 
non-signal trial the water dipper would raise into the chamber for 3 s as reward.
A rewarded lever press response for signal trials was considered a “hit” whereas 
a press on the opposite lever was considered a “miss”. A rewarded response on non­
signal trials was considered a “correct rejection”, whereas a press on the opposite lever 
was considered a “false alarm”. For both signal and non-signal trials, if the levers 
extended into the chamber and the animal did not press either lever within 3 s, then the 
trial was scored as an “omission”. All incorrect response trials were followed by a 
correction trial that was identical to the previous trial. A forced trial followed if 
animals did not respond correctly on three consecutive correction trials. Forced trials 
consisted of illumination of the panel light (for signal trials) or no illumination (for 
non-signal trials) followed by an extension of only the correct lever into the box until 
the lever was pushed or 90 s elapsed. The intertrial interval (ITI) was 12+/- 3 s and the 
house light was not illuminated during this stage of training. Once animals reached 
70% accuracy for both signal and non-signal trials for five consecutive days, they were 
moved to the next stage of training.
For the next stage of training, the rules of the task did not change, however 
some of the parameters were adjusted. First, the signal trials consisted of three different 
types of trials wherein the light would illuminate for 500, 100 or 25 ms in a semi­
randomized order. Second, the correction and forced trials were removed. Third, the 
ITI was decreased to 9 +/- 3 s. These alterations were to minimize the likelihood that 
the rat could predict the type or timing of a trial before it was initiated, therefore
requiring the animal to sustain attention throughout the entirety of the testing session
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and not memorize the trial order. Each testing period contained 9 blocks of 18 trials 
(for a total of 162 trials). In each block, there were 9 signal trials (3 trials at each signal 
duration) and 9 non-signal trials. The entire session took approximately 40 minutes to 
complete. Once the animals reached a criterion of 70% accuracy on the 500ms signal 
and non-signal trials for seven consecutive days they were considered to have reached 
criterion performance. See Figure 1 for portrayal of the final task.
Surgical Procedure. Once the rats reached criterion in the final task (on both 
signal and non-signal trials), they were considered ready to receive surgery. Each 
animal was anesthetized (90.0mg ketamine, 9.0 mg/kg xylazine, intraperitoneal 
injections) and placed in a stereotaxic surgical instrument. All surgical procedures took 
place under aseptic conditions. Holes were drilled over the appropriate locations and 
bilateral infusions made at AP: -1.3, ML: +/-2.7; DV: +2.5 (AP and ML relative to 
bregma; DV relative to IA). In each hemisphere, 0.5pi of saline (N=  8), or of GAT1- 
Saporin (0.4 pg/pl; Advanced Targeting Systems; N =  8) was administered through a 
26-gauge cannula attached to a 1.0 pi Hamilton syringe. Saline or GATl-Saporin 
infusions occurred over one minute and the needle was left in place for one minute to 
allow time for diffusion into the brain. After infusions, incisions were closed using 
surgical staples and animals were placed in their home cages to recover for one week. 
During this recovery, animals received ad libitum access to water containing 
acetaminophen (2.7 mg/ml) for three days following surgery and then tap water for 4 
days.
Post Surgery Procedure. After the recovery period, water deprivation was
reinstated, and the animals were then tested for at least 15 sessions on the same two-
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choice sustained attention task that they were trained on prior to surgery. In accordance 
with McQuail and Burk (2006), the task was then modified so that the animals were 
placed in the testing chamber, but the attention task did not begin for 10 minutes. This 
was in order for the animals to become accustomed to delay prior to the addition of 
scopolamine injections, as this delay would allow time for the drug to cross the blood 
brain barrier before beginning the task.
Intraperitoneal injections (ip) of the muscarinic receptor antagonist, 
scopolamine, were then administered prior to testing sessions using a 1-ml syringe. 
Each rat received ip injections of saline, 0.05 mg/kg, 0.1 mg/kg, and 0.2 mg/kg of 
scopolamine (McQuail & Burk, 2006). The order of injections was randomized for 
each animal and there were at least two days of drug-free behavioral testing between 
each of the injection sessions.
Behavioral Measures. Accuracy on signal and non-signal trials was computed 
using the formulae hits/ (hits + misses) and correct rejections/ (correct rejections + 
false alarms), respectively. Total number of omissions was determined separately from 
measures of accuracy. Overall task performance was calculated using a Vigilance 
Index (VI; McGaughy, Kaiser & Sarter, 1996). Proportions were created for hits and 
false alarms divided by total signal and total non-signal trials respectively. VI was 
calculated by entering those proportions into the formula (hits - false alarms) / (2 X 
(hits + false alarms) -  (hits + false alarms)2) with values ranging from 1 (indicating 
100% correct responses on signal and non-signal trials) to -1 (indicating a 100% 
incorrect responses on signal and non-signal trials).
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Perfusion/ Histological Procedure. Rats received an ip injection of 100.0 
mg/kg ketamine and 10.0 mg/kg xylazine. Once deemed sufficiently anesthetized, 10% 
sucrose and then 4% paraformaldehyde solutions were perfused intracardially 
throughout the circulatory system of the rat. The brain was then removed and placed 
into a 4% paraformaldehyde solution for at least 2 days and then transferred to a 30% 
sucrose solution in phosphate-buffered saline for cryoprotection. Sectioning was 
conducted using a freezing microtome (SM2000R; Leica Biosystems). Parallel 
sections (50 pM) were taken beginning at the formation of the anterior commissure and 
ending once the ventral portion of the hippocampus could be observed. After sections 
were taken they were stored at -20° C in an antifreeze solution until staining took 
place.
Sections were prepared for parvalbumin (PV) staining with three rinses of 
phosphate buffered saline (PBS). The sections then underwent a 10 minute period in 
0.5% H2O2, 0.3% Triton X-100 in PBS. Following PBS rinses the sections were 
immersed in 2% bovine serum albumin (Sigma; St. Louis, MO, USA), 5% donkey 
serum, and 0.3% Triton X-100 for 90 minutes and were then put into a mouse anti-PV 
solution (Sigma; 1:2000) and were left at room temperature on an orbital shaker over 
night. The next morning sections received PBS rinses and were incubated for 90 
minutes in a donkey anti-mouse secondary antibody (Chemicon, Temecula, CA, USA;
1:50), and were rinsed with TRIS buffered saline. The sections were then exposed to 
mouse peroxidase anti-peroxidase complexes for 90 minutes followed by the addition 
of 1.5 ml 3,3,-diaminobenzidine (DAB), 13.5 ml TRIS buffer, and 50 ml nickel 
ammonium sulfate.
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Acetycholinesterase (AChE) staining protocol was developed through the 
modification of method detailed by Tago, Kimura, & Maeda (1986). Sections were first 
placed into three 0.1M phosphate buffer (pH 7.4) rinses and were then incubated for 30 
minutes using a 0.1% H2O2 solution. Sections then received three maleate buffer 
(MAL; pH 6.0) rinses and were then immersed into an incubation of 200 ml MAL, 15 
mg acetylthiocholine iodide, 0.75 ml sodium citrate solution (0.03 g/ml), 1.5 ml cupric 
sulfate solution (0.007 g/ml) and 1.5 ml potassium ferricyanide solution (0.02 g/ml) for 
30 minutes. After 30 mM TRIS buffer (TRIS; pH 7.6) rinses the sections were placed 
into a solution of 50.0 mg of DAB and 0.375 g nickel ammonium sulfate in 125.0 ml of 
50.0 mM TRIS buffer (pH 6.2). About 12 drops of 0.1% H2O2 solution were then 
added to the sections until the tissue turned black. The sections then received three 
more TRIS rinses and were mounted on gelatin-coated slides and then cover slipped for 
examination.
Statistical Analyses. Statistical analyses were conducted using a series of 
mixed model analysis of variance (ANOVA) that included group (sham, lesion), 
scopolamine dose (Saline, 0.05 mg/kg, 0.1 mg/kg, 0.2 mg/kg) and, for signal trials, 
signal duration (500 ms, 100 ms, 25 ms) as factors. An alpha level was set to .05 and 
all analyses were conducted using IBM SPSS version 21 statistical software. 
Experiment 2
Subjects/ Apparatus. FBNF1 male hybrid rats (NIA Colony; N =  20), 3 
months at the beginning of the experiment, were used in this experiment. All housing, 
testing conditions and apparatuses were the same as in experiment 1.
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Two-Choice Sustained Attention/ Light-Location Discrimination Tasks.
Rats were shaped and trained on the two choice sustained attention task as detailed in 
experiment 1. Subjects continued to train until age 20 months. At that age, rats were 
divided into two experimental groups. The distracter- exposed group (n = 10) had the 
addition of a flashing house light (0.5 sec on; 0.5 sec off) while performing the task. 
The non-distracter-exposed group (n = 10) continued training in the sustained attention 
task with a continuously illuminated house light, as previously trained.
After 20 sessions of these distracter or non-distracter conditions, trials of a 
light-location discrimination task were randomly intermixed within blocks of the 
sustained attention task for both groups. For this light-location discrimination task, 
either the right or the left panel lights would illuminate for 500 ms. The two levers 
below the lights would then extend into the box. A correct response for these trials was 
a press on the lever below the light that was just illuminated. With the addition of the 
light-location discrimination task, the number of trials per block was increased from 18 
to 20 for a total of 180 trials per testing session. See Figure 2 for portrayal of light- 
location discrimination task.
For 20 consecutive sessions 40% of the trials within each block contained this
light-location discrimination and 60% of trials contained the standard sustained
attention task. These sessions contained 8 light-location discrimination trials (4 with
left light illumination and 4 with right light illumination) and 12 sustained attention
trials (6 signal, 2 each with 500, 100, 25 ms signals, and 6 non-signal) per block. The
number of trials containing the light-location discrimination task was then increased to
70% per block and 30% of trials were the sustained attention task. These 70% trials
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contained 14 light novel discrimination trials (7 with left light illumination and 7 will 
right light illumination) and 6 sustained attention trials (3 signal, 1 at 500, 100, 25 ms, 
and 3 non-signal) per block.
Drug Administration. After 20 sessions with 70% light-location 
discrimination trials and 30% sustained attention trials, a 10 minute wait was 
introduced similar to that in experiment 1 in order to allow animals to acclimate to the 
time needed for the drugs to fully cross the blood brain barrier. Subjects received ip 
injections of scopolamine with a 1-ml syringe prior to a testing session. All rats 
received doses of saline, 0.1 mg/kg, 0.2 mg/kg, and 0.4 mg/kg of scopolamine in a 
randomized, counterbalanced order. To minimize the likelihood that there were 
carryover effects of the drug, there were at least two days of drug-free behavioral 
testing between each injection day.
< Rats were then given ip injections of nicotine prior to testing sessions. The 
schedule and dosage was similar to that of scopolamine (saline, 0.1 mg/kg, 0.2 mg/kg, 
and 0.4 mg/kg; Grilly, Simon, & Levin, 2000) and administration Order was 
randomized with at least two days of behavioral testing in between each injection day.
Behavioral Measures. Performance on the two choice sustained attention task 
was determined by accuracy of hits for signal trials [hits / (hits + misses)] and correct 
rejections for non-signal trials [correct rejections/ (correct rejections + false alarms)]. 
For the light-location discrimination task, performance was determined by number of 
correct lever presses over total number of light-location discrimination trials when the 
animal pressed a lever (correct trials / correct trials + incorrect trials). Omissions were 
calculated separately for both tasks.
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Statistical Analysis. Statistical analyses for this experiment were conducted 
using IBM SPSS version 21 statistical software and alpha level was set to .05. Mix 
model ANOVAs were conducted to analyze the data collected.
Following distracter exposure (or not), performance in the sessions prior to 
drug injections was averaged into four blocks, each with five sessions (Block 1: 
Sessions 1-5, Block 2: Sessions 6-10, Block 3: Sessions 11-15, Block 4: Sessions 16- 
20). For the two choice sustained attention task, ANOVAs were conducted including 
factors such as distracter conditions (distracter, non-distracter), block (1, 2, 3, 4), and 
signal duration for signal trials (500, 100, 25 ms). Performance for the light-location 
discrimination task was analyzed using ANOVAs containing distracter condition 
(distracter, non-distracter) and block (1-4) as factors. Performance on the 40% light- 
location discrimination and 70% light-location discrimination sessions were analyzed 
separately.
Sustained attention and light-location discrimination data for scopolamine and 
nicotine sessions were analyzed separately according to the ANOVAs described above 
with the addition of scopolamine or nicotine dose as a factor (Saline, 0.1 mg/kg, 0.2 
mg/kg, 0.4 mg/kg).
Results 
Experiment 1
Behavioral Results. Analysis of post surgical performance for 15 sessions after 
recovery did not indicate any significant differences between the sham and lesioned 
animals (all p  > .06). One lesion animal was excluded from final data analys is because 
of high omission rates.
25
A group (sham, lesion) x scopolamine dose (Saline, 0.05 mg/kg, 0.1 mg/kg, 0.2 
mg/kg) x signal duration (500 ms, 100 ms, 25 ms) ANOVA was conducted for VI for 
the post drug injection sessions. There was a significant effect of group on VI value 
(F(l, 13) = 5.02,/? = .04) which indicated that lesions animals performed worse that 
sham animals. Observation of the data indicated that lesioned animals tended to 
perform worse following scopolamine injections, although the dose x group interaction 
was not significant. To explore this observation, separate one way ANOVAs with dose 
as a factor were conducted for sham and lesioned animals. There was no main effect of 
dose for rats in the sham group (F(3, 18) = 2.02,p  = .15; Figure 3) however, there was 
a significant main effect of dose for the lesion group animals (F(3, 21) = 3.61,/? = .03; 
Figure 4) which was driven by a significant difference in performance when 
comparing the saline to the 0.2 mg/kg dose condition when averaging across signal 
duration (t(l) -  2.57, p = .04). There were no differences involving group as a factor 
for hits or correct rejections (all p  > .23). There was no difference between the two 
groups for omissions at any dose (all p  > . 15).
Additionally, there was a significant main effect of scopolamine dose on VI
(F(3, 39) = 4.80, p  = .01; Figure 5). Paired samples t-tests revealed that all animals had
significantly poorer performance after the 0.2  mg/kg dose when compared to the saline
dose (*(14) = 2.93,/? = .01). The effects of scopolamine on VI were primarily due to
decreased signal detection performance, as evidenced by a significant main effect of
dose on percentage hits (F(3, 39) = 6.26,/? < .01; Figure 6) although there was also a
trend for decreased correct rejection performance for all animals (F(3, 39) = 2.22, p  =
.10; Figure 7). Follow up paired samples t- tests indicated that there was a difference in
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hits performance between the saline and 0.1 mg/kg dose (7(14) = 2.61,/? = .02) and the 
saline and the 0.2 mg/kg dose (t(\4) = 3.15,/? < .01) for all animals.
Histology Results. For several animals, the quality of the histological 
processing did not permit quantitative evaluation of the lesions, thus limiting this 
analysis to a qualitative evaluation. Infusion of GATl-saporin into the BF appeared to 
decrease the density of PV-positive neurons in the area, compared to the PV-positive 
fiber density in sham lesioned animals (Figure 8). This suggests that there was loss of 
GABAergic neurons within the BF as a result of bilateral infusions of GATl-saporin.
Acetycholinesterase (AChE) staining revealed that there were similar numbers 
of AChE-positive fibers within the parietal cortex for both GATl-saporin and sham 
lesion animals {Figure 9). This suggests that there was no loss of cortical cholinergic 
connections due to GATl-saporin lesions.
Experiment 2
Effects of Distracter Exposure. Prior to the introduction of the distracter, a
group x signal duration ANOVA revealed that there were no significant group
differences in performance on the two-choice sustained attention task prior to the
introduction of the distracter. The mean percent hits for the distracter- exposed animals
the three days prior to the addition of the distracter were as follows; M500-  87.32
(SEM= 0.55), M100= 66.24 (SEM=  1.76), M25 = 44.59 {SEM= .75), M Cr =  87.67
{SEM = 0.85). The mean percent hits for the non-distracter-exposed animals on the
same three days were as follows; Msoo= 84.62 (SEM= 0.65), Mioo = 75.06 (SEM =
0.90), M25 = 44.25 (SEM=  1.50), M Cr =  85.99 (SEM=  0.15). To evaluate performance
after the introduction of the distracter but before the addition of the light-location
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discrimination task, a block (Block 1: Sessions 1-5, Block 2: Sessions 6-10, Block 3: 
Sessions 11-15, Block 4: Sessions 16-20) x signal duration (500ms, 100ms, 25ms) x 
condition (distracter, non-distracter) ANOVA was conducted to evaluate hits 
performance on signal trials. There was a significant block x signal duration x 
condition interaction (F(6, 108) = 2.14, p  = .02).
Independent samples /-tests were conducted, comparing the distracter- and non- 
distracter- exposed animals at each block, to determine the basis for the significant 
three-way interaction. These analyses showed that the percentage of hits by the 
distracter animals was lower when compared to the non-distracter rats for the 100 ms 
signal duration trials during block 1 (/(l 8) = 2.74, p  = .01) and for the 500 ms trials 
(/(18) = 2.58, p  = .02) and 100 ms trials (/(18) = 4.46,/? = .049 during block 2 {Figure 
10; Figure 11). There were no significant differences in hits at any signal duration 
between the two groups during block 3 (all p  > .16) or block 4 (all p  > .10). Overall, 
there was decreased performance across the first 10 sessions (blocks 1 and 2 ) after the 
addition of the distracter but performance recovered during the final 10 sessions 
(blocks 3 and 4).
Furthermore, a block x signal duration x condition ANOVA conducted for VI 
performance did not yield a significant three way interaction (F(6 , 108) = 2.13,/? =
.06). For non-signal trials and omissions, block x condition ANOVAs did not yield any 
significant interactions (all p  > .09).
Task Performance Following Inclusion of Light-Location Discrimination
Task. After the introduction of the light-location discrimination task, a block (Block 1:
Sessions 1-5, Block 2: Sessions 6-10, Block 3: Sessions 11-15, Block 4: Sessions 16-
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20) x signal duration (500 ms, 100 ms, 25 ms) x condition (distracter, non-distracter) 
ANOVA was executed to evaluate VI and hits for the sustained attention task and 
block x condition ANOVAs were conducted to evaluate performance on non-signal 
trials and the light-location discrimination task. There were no significant differences 
between distracter and non-distracter group performance on any measure for the 
sustained attention task and the light-location discrimination task during the sessions 
with 40% trials of the light-location discrimination task (all p  > .09).
During the 70% light-location discrimination sessions, there was a significant 
signal duration x condition interaction when assessing relative hits on the sustained 
attention task (F(2, 36) = 4.05, p  = .03). This interaction was due to a significant 
difference in performance between the distracter and non-distracter rats for the 25 ms 
trials (/(l 8) = 3.26,/? < .01). The distracter-exposed animals had a higher percentage of 
hits than the non-distracter animals (Figure 12). There were no differences in 
performance between the groups when evaluating VI, correct rejections or performance 
on the light-location discrimination task for the 70% sessions (all p  > .15)
Scopolamine Administration. The effects of scopolamine along with distracter
condition on sustained attention performance was analyzed using dose (Saline, 0.1
mg/kg, 0.2 mg/kg) x signal duration (500 ms, 100 ms, 25 ms) x condition (distracter,
non-distracter) ANOVAs for the signal, and non-signal (without the signal duration
factor) trials. The 0.4 mg/kg dose was removed from analyses because of the high
omission rate (M= 163.50). There was a significant effect of scopolamine dose on
signal trial performance for all animals (F(2, 36) = 5.67, p  = .01; Figure 13) and on VI
(F(2, 22) -  3.52,p  = .047). These effects were mainly due to a significant difference
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between hits after the saline and 0.2 mg/kg scopolamine injections (7(9) = 2.99, p  =
.02).
There were no significant effects involving condition or scopolamine dose as 
factors for correct rejections on the sustained attention task (all p  > .09). A 
scopolamine dose (Saline, 0.1 mg/kg, 0.2 mg/kg) x condition (distracter, non- 
distracter) ANOVA was conducted to evaluate performance on the light-location 
discrimination task which indicated no significant difference in performance depending 
on scopolamine dose or condition (all p  > .46).
Nicotine Administration. ANOVAs were conducted to evaluate the effect of 
nicotine on the distracter and non-distracter animals. Sustained attention task 
performance was assessed using nicotine dose (Saline, 0.1 mg/kg, 0.2 mg/kg) x signal 
duration (500 ms, 100 ms, 25 ms) x condition (distracter, non-distracter) ANOVAs for 
signal trials, and similar ANOVAs (without the signal duration factor) for non-signal 
and light-location discrimination trials. Because of high omission rates the 0.4 mg/kg 
nicotine dose condition was not included in data analysis (M= 176.10).
There was a significant effect of nicotine dose on signal trials (F(2, 36) = 4.28,
p  = .02; Figure 14) for all animals. Follow-up paired samples £-tests revealed that there
was a difference in hits when comparing the saline and the 0.2 mg/kg dose (/(l 9) =
2.11,p = .01). Performance on the non-signal trials revealed a significant main effect
of dose (F(2, 36) = 8.17,/? < .01; Figure 15). There was a significant difference in
performance on non-signal trials when comparing saline to 0.1 mg/kg trials (£(19) =
2.05, z? = .054) and 0,2 mg/kg trials (£(19) = 3.37,/? < .01). In all of these cases
performance was worse after nicotine injection when compared to saline. In
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combination, there was also a main effect of nicotine dose on VI (F(2, 10) = 5.38,/? = 
.03). Follow-up paired samples /-tests reveled a significant difference in performance 
when comparing the saline to the 0.2 mg/kg dose condition (/(l5) = 2.80, p  = .01).
A nicotine dose x condition ANOVA indicated that there was no significant 
main effect of nicotine dose when comparing the distracter-exposed and non-distracter- 
exposed animals for the light-location discrimination task (F(2, 36) = 1.92, p  = .16).
Discussion
The main purpose of the present experiments was to investigate the 
neurobiological factors that contribute to age-related changes in attention and cognitive 
flexibility. Therefore, these experiments may provide a stepping stone to better 
understand these potentially life altering declines.
Experiment 1: Interactions Between Basal Forebrain GABAergic Neurons and 
Cholinergic Muscarinic Receptors
The main results from experiment 1 reveal an interaction between BF
GABAergic neurons and the cholinergic system that affects attentional task
performance. There were no differences in attentional performance between the
GABAergic lesion group and the sham lesion group prior to scopolamine injections.
However, with the addition of injections of scopolamine, GABAergic lesioned animals
exhibited lower VI (signifying decreased attentional performance on both signal and
non-signal trials) scores compared to sham rats. This group difference was driven
largely by decreased attentional performance by lesioned animals when comparing the
saline to the 0.2 mg/kg dose of scopolamine. When analyzing the trial types
individually, the deficit could not be specified to hits or correct rejections. Exploratory
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analyses indicated that the difference in the effect of scopolamine on VI between the 
two groups indicates that lesioned animals were more susceptible to the attentional 
deficits caused by the blocking of muscarinic receptors. There were also no significant 
differences between the two groups when analyzing the omission data which supports 
that the lesion and drug-induced changes in task performance are not due to changes in 
motivation or motoric abilities. Overall the results from experiment 1 indicate that 
lesioning BF GABAergic neurons and blocking the muscarinic receptor system causes 
a decrease in attentional performance.
Results from experiment 1 also indicated a decrease in VI in both the sham and 
lesion groups as scopolamine dose increased. This effect was mainly driven by a 
significant main effect of dose on decreased signal detection performance (percent 
hits). These results are consistent with findings of previous studies that highlight the 
successful use of scopolamine to decrease attentional performance on signal trials 
through the blocking of muscarinic receptors (i.e. Johnson & Burk, 2006; McQuail & 
Burk, 2006).
The results from experiment 1 are complementary to the findings of Burk and
Sarter (2001), Lau and Salzman (200.8) and Yi and colleagues (2014) by highlighting
the importance of non-ACh neurons within the BF on attention. However, this
experiment goes beyond these findings through selectively lesioning GABAergic
neurons in the BF and then acutely blocking the muscarinic receptors. By being able to
differentially render these systems inactive we are better able to understand how each
system moderates attention individually and then in combination with one another. The
lesioned animals did not differ in performance from the sham animals immediately
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after surgery. However, there was a main effect of group once drug administration 
procedures began. The data suggest that there was a trend for group differences post 
lesion that became significant with drug administration. The results from this 
experiment indicate that although the loss of GABAergic connections in the BF 
independently does not lead to a decrease in attentional performance, the loss of 
GABAergic BF neurons makes an organism more vulnerable to the negative attentional 
effect due to the blocking of muscarinic receptors within the cortex.
Interestingly, the results from GABAergic lesions and scopolamine injections 
in this experiment differentially affected attentional performance beyond what has been 
shown in previous studies. Research that has solely lesioned BF ACh neurons has 
typically shown a pattern of attentional deficits through decreased hit rate (poorer 
performance on signal trials). Moreover, Burk and Sarter (2001) performed 
indiscriminate lesions of both GABAergic and cholinergic neurons using ibotenic acid. 
The resulting attentional deficit was highlighted through an increase in false alarms 
(indicating incorrect responses to non-signal trials). In experiment 1, differences 
between the lesion and sham groups after scopolamine injections were observed when 
analyzing VI (a combination of both hits and correct rejections). The discrepancy in 
attentional deficits indicates a difference in the neurobiological responses to the three 
types of lesions. In experiment 1 there was an initial loss of GABAergic neurons due to 
the lesion while ACh neurons were preserved, was not until the muscarinic receptors 
were blocked that accuracy significantly declined for both signal and non-signal trials. 
This indicates that disrupting these two systems caused a decreased ability to
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differentiate between the signal and non-signal indicators, possibly reflecting a limited 
capacity to apply the proper rules for each trial type.
Experiment 2: The Effects of Introducing a Visual Distracter on Plasticity in Aged 
Rats
The goal for experiment 2 was to measure the effects of the addition of a
" \
distracter (flashing houselight) on attentional performance in a learned sustained
attention task and a new light-location discrimination task in aged rats. The effects of
the initial distracter exposure decreased hits are longer signal durations during the first
10 sessions for the distracter-exposed group compared to the non-distracter-exposed
rats. This effect was found at the longest signal durations which indicates that the
difference in performance between the two groups is not due to a deficit in perception
of the signal. Rather, it suggests a deficit in the processing of and application of the
rules following that signal. If this is the case, the 500 ms signal would be where the
errors would occur because it is the most likely signal duration to be detected, but
perhaps errors occurred in the inability for the animals to apply the rules after the
detection of the signal. During blocks 3 and 4 there was no difference between the
distracter- and non-distracter-exposed groups on sustained attention task performance.
These results indicate that although there was an initial decrease in hits due to the
flashing houselight, the animals were able to compensate for the added distracter and
regain attentional performance similar to that of the non-distracter-exposed animals.
The two groups did not differ on sustained attention or light-location
discrimination task trials after the modification of 40% blocks of the light-location
discrimination task. However, there was a difference during the 70% blocks of the
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light-location discrimination task between the two groups on the sustained attention 
task. Specifically, the distracter-exposed rats Had a higher percentage hit rate at the 25 
ms signal duration compared to the non-distracter-exposed rats. There were no 
differences between the groups on any other measure of sustained attention or the light- 
location discrimination task indicating that the distracter-exposed animals were able to 
surpass the non-distracter-exposed animals at the shortest signal duration on the 
sustained attention task while maintaining performance on other measures of attention. 
These results suggest that the animals’ ability to compensate for the addition of the 
distracter increased behavioral or cognitive flexibility. The higher level of hits at the 
shortest (the most attentionally taxing) signal duration by the distracter-exposed 
animals above the non-distracter-exposed animals while not sacrificing performance on 
any other measure of attention, suggests that these animals were able to maintain 
higher levels of attention compared with non-distracter-exposed rats.
This effect is similar to but not as pronounced as the results found in Hirsh and 
Burk (2013). In the previous study, the distracter-exposed rats showed improved 
performance beyond the non-distracter-exposed rats in both the sustained attention and 
the light-location discrimination tasks whereas the aged animals in the current 
experiment only displayed better performance during the sustained attention task at the 
25 ms signal duration. Also, it took the distracter-exposed animals 10 sessions to regain 
attentional performance similar to the non-distracter-exposed animals. Previous 
research showed that younger animals regained attentional performance after 1 session 
(Hirsh & Burk, 2013). These discrepancies indicate that although aged animals do have
35
sufficient neuroplasticity to benefit from overcoming an increase in attentional 
demand, the effects are not as robust as what has been seen in younger animals.
There was a decrease in hits for both groups after the administration of the 
highest dose of scopolamine. This further confirms the negative effects that muscarinic 
receptor blockade has on attentional performance. Moreover, there were no differences 
between the distracter-exposed and non-distracter-exposed animals’ performance after 
scopolamine administration. Therefore, the addition of the distracter did not interact 
with scopolamine dose to change attentional performance. Scopolamine did not have a 
significant effect on performance on the light-location discrimination task. This 
selective effect of scopolamine may implicate muscarinic receptors in certain aspects 
of attention, such as switching between signal and non-signal trials, that are necessary 
for the two-choice sustained attention task but not for the light-location discrimination 
task for aged animals.
There was also a decrease in hit (correct responses to a signal trial) and correct 
rejection (correct responses to a non-signal trial) percentage following injections of 
nicotine for both distracter- and non-distracter-exposed rats. This is counter to previous 
research that has found that the stimulation of nicotinic receptors increases attention in 
both animals and humans (i.e. Rezvani & Levin, 2001). This could be due to the rat’s 
age (beyond 20 months). It also indicates that, similar to scopolamine, the addition of 
the distracter did not alter the effects of nicotine and there was no significant effect of 
nicotine on performance on the light-location discrimination task.
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Limitations and Future Directions
There are multiple ways to build upon the findings from experiment 1. First, the 
ip injections of scopolamine used in this experiment blocked muscarinic receptors 
throughout the brain and periphery. Future research could focus on altering the 
cholinergic system in precise cortical areas. Blocking muscarinic receptors in the 
prefrontal cortex may be of particular interest because previous research has indicated 
that the prefrontal cortex is abundant in ACh neurons and controls executive 
functioning (Fuster, 1988).
Furthermore, it would be beneficial to investigate how blocking the different 
types of cholinergic receptors would affect attentional performance. ACh binds to 
nicotinic and five different types of muscarinic receptors (M1-M5). Previous research as 
shown that blocking Mi receptors using dicyclomine significantly decreases attentional 
performance in the same sustained attention task as used in the present experiments 
(Robinson, Mangini, & Burk, 2012). The results from this study showed that blocking 
Mi receptors decreased performance at the longest signal duration during the two- 
choice sustained attention task with and without the presence of a flashing houselight 
distracter. Therefore, selectively blocking this class of receptors may have differing 
effects on attentional performance and further specify which aspects of the cholinergic 
system interact with the GABAergic system to affect attention.
Because of the decrease in glutamate neurons associated with aging and the
inverse relationship between glutamate and GABA neurons (Masliah, Hansen, Alford,
Deieresa, & Mallory, 1996) it would be of interest to go beyond the findings of
Experiment 1 to investigate the potential interaction between BF glutamate neurons
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and the cholinergic system that may affect attention. This could be carried out through 
the development of an immunotoxin that could be used to surgically lesion glutamate 
neurons within the BF and then pharmacologically manipulating the cholinergic system 
through ip injections of scopolamine and nicotine.
Further studying the effects of GABAergic lesions in aged animals would 
provide an important extension of experiment 1. An increase in GAB A activity has 
been cited as a factor in cognitive decline for both normal aging and in AD 
(Marczynski, 1998). Therefore, perhaps lesioning GABAergic neurons within different 
brain regions could be protective against this increase in GABAergic neurons 
associated with aging.
Future studies could also investigate the relationship between the GABAergic 
and cholinergic systems and its effect on attention in aged animals. For example, an 
experimenter could administer GABAergic lesion early in life, in early adulthood or in 
advanced age and observe the effects of cholinergic manipulations due to nicotine and 
scopolamine injections on attentional performance once the animals have aged. A 
potential difference in the pattern in attentional performance due to the timing of the 
lesions may reveal important data on the age that vulnerability is highest for the effects 
of changes within GABA and glutamate systems to interact with the cholinergic system 
to contribute to attentional cognitive decline. For example, perhaps lesions that occur 
earlier in life will force the cholinergic system to compensate more for the loss of these 
neurons throughout life and rely more on these connections to perform in attention 
demanding tasks. Therefore, there would be a more drastic effect of manipulations to
the cholinergic system on attention if the lesions occurred at an earlier age.
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There are also experimental manipulations that could further the findings from 
experiment 2. One future study could explore the effect of the addition of a flashing 
houselight distracter in combination to ip injections of scopolamine and nicotine 
injections on attentional plasticity in younger animals. The results from this study 
would be comparable to the results from Hirsh and Burk (2013) by investigating how 
pharmacological manipulations to the cholinergic system may change plasticity at a 
younger age and to the current experiment by examining if cholinergic manipulations 
have a different effect on younger animals as compared to aged animals. Young 
animals would most likely show the typical effects of nicotine and benefit from 
nicotine administration counter to the results found in experiment 2 where nicotine 
decreased attentional performance in aged animals.
Additionally, future studies could surgically lesion BF cholinergic neurons
using 192 IgG-saporin in both young and aged animals and compare performance on
the sustained attention task and light-location discrimination task after the addition of
the distracter. During experiment 2 manipulations to the cholinergic system were very
selective and did not completely render the cholinergic system inactive (scopolamine
only blocking muscarinic receptors and nicotine only activating nicotinic receptors).
The use of 192 IgG-saporin would produce a more general inactivation within the
cholinergic system within one brain region through destroying ACh neurons within the
area of infusions. Rather than acutely manipulating specific receptors within the
cholinergic system throughout the entirety of the brain this study would selectively
lesion cholinergic connections projecting from the BF and investigate their effect on
behavioral flexibility. Furthermore, these immunotoxic lesions could be administered
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to specific cortical areas, for example the prefrontal cortex, to see how cholinergic 
connections within that region interact with the flashing houselight distracter to affect 
attention.
Because of the preceding cholinergic and GABAergic theories of cognitive 
decline, future studies could integrate the methods from experiment 1 and experiment 2 
to look at the interaction between of the cholinergic and GABAergic systems that may 
lead to changes in both neuroplasticity and attention. This can be carried out in a 
number of ways. Altering the timing of the pharmacological and task manipulations 
could provide further insight into the interaction between these two neurotransmitter 
systems and attention and neuroplasticity. For example, the lesion to the BF 
GABAergic system could occur first followed by the addition of the distracter. Then 
the light-location discrimination task would be introduced the cholinergic system 
manipulated through ip injections of scopolamine and nicotine. Also, the addition of 
the distracter could take place first followed by the BF GABAergic lesions and then the 
introduction of the light-location discrimination task with pharmacological cholinergic 
manipulations. These methods would test whether the ability to compensate for the 
distracter and maintain attentional performance prior to the loss of BF GABAergic 
neurons could be protective against the attention deficits.
Overall, these studies have helped to advance the understanding of two major
symptoms of cognitive decline associated with age: decline in attention and in
neuroplasticity. Understanding the neurobiological processes that underlie these two
processes can help to better understand their origins and causes. Much of the focus of
the neurobiological causes of AD is targeted at the formation of p-amyloid plaques and
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neurofibrillary tangles. Additionally, both ACh and GABAergic transmission have 
been implicated the formation of P-amyloid. Previous research has shown that 
activation of Mi receptors can lead to decrease p-amyloid (Hock, 2001) and p-amyloid 
plaques disrupt glutamatergic and GABAergic transmission within the brain (Nava- 
Mesa, Jimenez-Diaz, Yajeya, & Navarro-Lopez, 2014). Perhaps a more holistic 
understanding of the underlying mechanisms (both neurotransmitter and 
neurobiological changes) through which decreases in attention and neuroplasticity 
manifest will lead to a more complete and better understanding of AD as well as 
normal age related cognitive decline.
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Figure 1. A visual representation of the two-choice sustained attention task. Animals 
received water access after correctly pressing the trained lever after to signal or non­
signal prompts. The correct response lever on each trial type was counter balanced for 
half of the rats.
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Figure 2. A visual representation of the light-location discrimination task used in 
experiment 2. For this task, rats had to indicate which of two signal lights illuminated 
by pressing the lever under the light to receive a reward of water.
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Figure 3. There is a trend of decrease performance as scopolamine dose increases and 
signal duration decreases for the sham animals. However, there is no significant 
difference in performance depending on scopolamine dose; p  = .15
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Figure 4. When comparing to the sham graph above there is a similar trend of 
decreased performance at higher doses of scopolamine and shorter signal trials. 
However, there is a significant decrease in performance after the 0.2 mg/kg dose; p  = 
.03.
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Figure 5. All animals (both sham and lesion) displayed a significant decrease in VI as 
scopolamine dose increased; p  = .01.
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Figure 6. As scopolamine dose increased, all animals showed a significant decrease in 
the hit rate; p  = .001.
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Figure 7. As scopolamine dose increased, all animals showed a non-significant trend of 
decreased accuracy on non-signal trials; p  = .08.
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Sham lesion GATl-saporin induced lesion
,
Figure 8. This figure depicts parvalbumin (PV) stained BF neurons after A) sham 
lesion and B) GATl-saporin lesion to bilateral hemispheres at 40x magnification from 
experiment 1. The GATl-saporin lesion shows a decrease in PV-positive neurons 
compared to the sham lesion.
57
Sham lesion GATl-saporin induced lesion
Figure 9. This figure depicts acetycholinesterase (AChE) staining within parietal 
cortex in a A) sham lesioned and B) GATl-saporin lesioned animal at 20x 
magnification from experiment 1. These figures show similar preservation AChE 
positive neurons within the cortex for both the sham and lesion groups.
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Figure 10. Hit rate on the two-choice sustained attention task for block 1. There was a 
significant difference in hits for the 100ms trials where the non-distracter rats 
performed better than the distracter animals; p  = .01.
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Figure 11. Hit rate in the two-choice sustained attention task for block 2 of this is 
illustrated here. Non-distracter animals had a significantly higher percentage of hits for 
both the 500 and 100 ms trials than the distracter animals; all p  < .05.
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Figure 12. Hits performance on the two-choice sustained attention task during the 70% 
light-location discrimination task. During these sessions, the distracter animals had a 
significantly higher percentage of hits during the 25ms signal duration trials,/? = .01.
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Figure 13. There was a significant effect of scopolamine dose on hits performance for 
all animals,/? = .01, which was mainly due to a difference in performance between the 
saline and 0.2 mg/kg doses.
6 2
Effect of Nicotine on Hits
Dose (m g'kg)
Figure 14. There was a significant effect o f nicotine dose on hits performance for all 
animals, p  = .02, which was mainly due to a difference in performance between the 
saline and 0.2 mg/kg doses.
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Figure 15. Nicotine dose had a significant effect on non-signal trials,/? < .01 where 
saline performance was significantly higher than both 0.10 mg/kg and 0.20 mg/kg 
performance.
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